SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-123965
Filing Date
2022-04-27
Accepted
2022-04-27 17:24:28
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d142348ds3.htm S-3 395840
2 EX-1.2 d142348dex12.htm EX-1.2 195627
3 EX-4.6 d142348dex46.htm EX-4.6 323005
4 EX-4.8 d142348dex48.htm EX-4.8 96428
5 EX-4.9 d142348dex49.htm EX-4.9 97715
6 EX-4.10 d142348dex410.htm EX-4.10 85659
7 EX-5.1 d142348dex51.htm EX-5.1 31158
8 EX-23.1 d142348dex231.htm EX-23.1 1688
9 EX-FILING FEES d142348dexfilingfees.htm EX-FILING FEES 27067
10 GRAPHIC g142348cooley.jpg GRAPHIC 3741
11 GRAPHIC g142348g04u94.jpg GRAPHIC 46277
  Complete submission text file 0001193125-22-123965.txt   1320205
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264521 | Film No.: 22861073
SIC: 2834 Pharmaceutical Preparations